Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 7
2000 12
2001 16
2002 27
2003 38
2004 47
2005 69
2006 85
2007 64
2008 74
2009 57
2010 50
2011 63
2012 47
2013 56
2014 36
2015 44
2016 40
2017 49
2018 43
2019 29
2020 45
2021 36
2022 35
2023 37
2024 39
2025 20
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,035 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF. Meyerhardt JA, et al. JAMA. 2021 Apr 6;325(13):1277-1286. doi: 10.1001/jama.2021.2454. JAMA. 2021. PMID: 33821899 Free PMC article. Clinical Trial.
INTERVENTIONS: Patients were randomized to receive adjuvant FOLFOX (every 2 weeks) for 3 vs 6 months with or without 3 years of celecoxib (400 mg orally daily; n = 1263) vs placebo (n = 1261). This report focuses on the results of the celecoxib randomization. ...Adh …
INTERVENTIONS: Patients were randomized to receive adjuvant FOLFOX (every 2 weeks) for 3 vs 6 months with or without 3 years of celecoxib …
Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
Shayeganmehr D, Ramezannia F, Gharib B, Rezaeilaal A, Shahi F, Jafariazar Z, Afshar M. Shayeganmehr D, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1571-1581. doi: 10.1007/s00210-022-02339-8. Epub 2022 Nov 24. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36418469 Clinical Trial.
However, due to reported gastrointestinal and cardiovascular toxicity following its long-term administration, celecoxib topical application would be a safe alternative for skin disorders. In this work, first, we formulated and optimized a topical hydrogel of celecoxib …
However, due to reported gastrointestinal and cardiovascular toxicity following its long-term administration, celecoxib topical appli …
Celecoxib use and circulating oxylipins in a colon polyp prevention trial.
Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA. Martinez JA, et al. PLoS One. 2018 Apr 26;13(4):e0196398. doi: 10.1371/journal.pone.0196398. eCollection 2018. PLoS One. 2018. PMID: 29698447 Free PMC article. Clinical Trial.
Using patient samples from the randomized, placebo-controlled phase III selenium/celecoxib (Sel/Cel) trial for the prevention of colorectal adenomatous polyps, we analyzed plasma concentrations of 74 oxylipins in a subset of participants who received celecoxib (n = …
Using patient samples from the randomized, placebo-controlled phase III selenium/celecoxib (Sel/Cel) trial for the prevention of colo …
Modulation effects of different treatments on periaqueductal gray resting state functional connectivity in knee osteoarthritis knee pain patients.
Zhou J, Zeng F, Cheng S, Dong X, Jiang N, Zhang X, Tang C, He W, Chen Y, Sun N, Zhou Y, Li X, Hu S, Sun R, Wintermark M, Yang W, Liang F, Li Z. Zhou J, et al. CNS Neurosci Ther. 2023 Jul;29(7):1965-1980. doi: 10.1111/cns.14153. Epub 2023 Mar 8. CNS Neurosci Ther. 2023. PMID: 36890655 Free PMC article. Clinical Trial.
Celecoxib capsules were continuously given orally to patients in the SC group at a dosage of 200 mg daily for 2 weeks. ...Acupuncture could modulate vlPAG rs-FC with brain regions associated with cognitive control, attention, and reappraisal for knee pain relief in KOA pat …
Celecoxib capsules were continuously given orally to patients in the SC group at a dosage of 200 mg daily for 2 weeks. ...Acupuncture …
Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial.
Nikanne E, Kokki H, Salo J, Linna TJ. Nikanne E, et al. Otolaryngol Head Neck Surg. 2005 Feb;132(2):287-94. doi: 10.1016/j.otohns.2004.09.005. Otolaryngol Head Neck Surg. 2005. PMID: 15692543 Clinical Trial.
Sixty minutes before anesthesia induction and 12 hours after, the patients received a 200-mg celecoxib, a 100-mg ketoprofen, or a placebo capsule. After discharge, patients were prescribed either celecoxib or ketoprofen capsules to be taken every 12 hours. ...One …
Sixty minutes before anesthesia induction and 12 hours after, the patients received a 200-mg celecoxib, a 100-mg ketoprofen, or a pla …
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial.
Tu L, Zhao M, Wang X, Kong Q, Chen Z, Wei Q, Li Q, Yu Q, Ye Z, Cao S, Lin Z, Liao Z, Lv Q, Qi J, Jin O, Pan Y, Gu J. Tu L, et al. Front Immunol. 2022 Aug 26;13:967658. doi: 10.3389/fimmu.2022.967658. eCollection 2022. Front Immunol. 2022. PMID: 36091030 Free PMC article. Clinical Trial.
CONCLUSION: Etanercept with or without celecoxib decreases inflammation detected by MRI at 1 year compared to celecoxib alone in active AS patients. The combination of etanercept and celecoxib was superior to celecoxib alone for the primary clinical re …
CONCLUSION: Etanercept with or without celecoxib decreases inflammation detected by MRI at 1 year compared to celecoxib alone …
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Obeid S, Libby P, Husni E, Wang Q, Wisniewski LM, Davey DA, Wolski KE, Xia F, Bao W, Walker C, Ruschitzka F, Nissen SE, Lüscher TF. Obeid S, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3;8(6):611-621. doi: 10.1093/ehjcvp/pvac015. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35234840 Clinical Trial.
Concerns remain regarding the relative incidence and severity of adverse cardiorenal effects, particularly in arthritis patients with established cardiovascular (CV) disease or risk factors for disease as illustrated by the PRECISION (Prospective Randomized Evaluation of Celec …
Concerns remain regarding the relative incidence and severity of adverse cardiorenal effects, particularly in arthritis patients with establ …
Efficacy and safety of SKCPT in patients with knee osteoarthritis: A multicenter, randomized, double-blinded, active-controlled phase III clinical trial.
Bin SI, Lee MC, Kang SB, Moon YW, Yoon KH, Han SB, In Y, Chang CB, Bae KC, Sim JA, Seon JK, Park KK, Lee SJ, Kim YM. Bin SI, et al. J Ethnopharmacol. 2025 Jan 30;337(Pt 2):118843. doi: 10.1016/j.jep.2024.118843. Epub 2024 Sep 18. J Ethnopharmacol. 2025. PMID: 39303963 Free article. Clinical Trial.
AIM OF THE STUDY: We aimed to evaluate the non-inferiority of SKCPT to celecoxib and safety for treating knee OA. MATERIALS AND METHODS: This multicenter, randomized, double-blind, phase III clinical trial enrolled adults with primary knee OA who were randomized (1:1) to S …
AIM OF THE STUDY: We aimed to evaluate the non-inferiority of SKCPT to celecoxib and safety for treating knee OA. MATERIALS AND METHO …
A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain.
Salo DF, Lavery R, Varma V, Goldberg J, Shapiro T, Kenwood A. Salo DF, et al. Acad Emerg Med. 2003 Jan;10(1):22-30. doi: 10.1111/j.1553-2712.2003.tb01972.x. Acad Emerg Med. 2003. PMID: 12511311 Free article. Clinical Trial.
OBJECTIVE: Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used to treat pain. The objective of this study was to compare the efficacies of celecoxib and ibuprofen for the treatment of acute pain. ...CONCLUSIONS: No significant difference exists among em …
OBJECTIVE: Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used to treat pain. The objective of this study was to compare …
1,035 results